TREATMENT OF PARKINSONISM - BROMOCRIPTINE, CARBIDOPA-LEVODOPA, AND LEVODOPA COMPARED IN A DOUBLE-BLIND-STUDY

被引：0
|
作者：
KARTZINEL, R
PERLOW, M
TEYCHENNE, PF
GIELEN, AC
GILLESPIE, MM
CALNE, DB
机构：
来源：
NEUROLOGY | 1976年 / 26卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：372 / 372
页数：1
相关论文
共 50 条
  • [21] Xanthonychia Due to Staining From Carbidopa-Levodopa
    Hwang, Jonathan Kyle
    Lipner, Shari R.
    DERMATOLOGY PRACTICAL & CONCEPTUAL, 2023, 13 (03):
  • [22] Possible serotonin syndrome with carbidopa-levodopa and linezolid
    Pettit, N. N.
    Alonso, V.
    Wojcik, E.
    Anyanwu, E. C.
    Ebara, L.
    Benoit, J. -L.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2016, 41 (01) : 101 - 103
  • [23] CARBIDOPA-LEVODOPA AND SELEGILINE DO NOT AFFECT PLATELET MITOCHONDRIAL-FUNCTION IN EARLY PARKINSONISM
    SHULTS, CW
    NASIRIAN, F
    WARD, DM
    NAKANO, K
    PAY, M
    HILL, LR
    HAAS, RH
    NEUROLOGY, 1995, 45 (02) : 344 - 348
  • [24] COMPARISON OF LEVODOPA WITH CARBIDOPA OR BENSERAZIDE IN PARKINSONISM
    GREENACRE, JK
    PETRIE, A
    COXON, A
    REID, JL
    LANCET, 1976, 2 (7982): : 381 - 384
  • [25] Double-Blind Trial of Levodopa/Carbidopa/Entacapone Versus Levodopa/Carbidopa in Early Parkinson's Disease
    Hauser, Robert A.
    Panisset, Michel
    Abbruzzese, Giovanni
    Mancione, Linda
    Dronamraju, Nalina
    Kakarieka, Algirdas
    MOVEMENT DISORDERS, 2009, 24 (04) : 541 - 550
  • [26] PROLONGED SERUM LEVODOPA LEVELS WITH CONTROLLED-RELEASE CARBIDOPA-LEVODOPA IN THE TREATMENT OF PARKINSONS-DISEASE
    HUTTON, JT
    ALBRECHT, JW
    ROMAN, GC
    KOPETZKY, MT
    ARCHIVES OF NEUROLOGY, 1988, 45 (01) : 55 - 57
  • [27] Use of carbidopa-levodopa in a patient with hydrocephalus and frozen movement
    Aggarwal, S
    Childers, MK
    Jimenez, D
    BRAIN INJURY, 1997, 11 (11) : 831 - 836
  • [28] Quality control of benserazide-levodopa and carbidopa-levodopa tablets by capillary zone electrophoresis
    Fanali, S
    Pucci, V
    Sabbioni, C
    Raggi, MA
    ELECTROPHORESIS, 2000, 21 (12) : 2432 - 2437
  • [29] SINGLE-BLIND DOUBLE OBSERVER-CONTROLLED STUDY OF LEVODOPA/CARBIDOPA VS BROMOCRIPTINE IN UNTREATED PARKINSON PATIENTS
    OLANOW, CW
    ARCHIVES OF NEUROLOGY, 1988, 45 (02) : 206 - 206
  • [30] New formulation:: Parcopa®, Schwarz pharma carbidopa-levodopa
    不详
    GERIATRICS, 2004, 59 (11) : 17 - 17
12345